Jackey Choi
About
Jackey Choi is from South Korea. Jackey is currently Partner/Head Of Strategic Planning at J&Partners. Jackey also works as Partner/Head of Strategic Planning at J&Partners, a job Jackey has held since Jan 2013. In Jackey's previous role as a General Manager of Business Planning at J&J Management, Jackey worked in until Sep 2006. Prior to joining J&J Management, Jackey was a Manager of Business Planning and New Business Development at Gaeasoft Corp and held the position of Manager of Business Planning and New Business Development. Prior to that, Jackey was a Manager of Business Planning and New Business Development at Dreammusic Co. LTD (Subsidiary of CJ Group) from Mar 2000 to Mar 2001.
Jackey Choi can be found on Finalscout.com, where members can access Jackey Choi's email for free. Finalscout is a professional database with more than 500 million business professional profiles and 200 million company profiles.
Jackey Choi's current jobs
Extensive Strategic Planning, Marketing, Sales, Finance, MIS, and International experiences including: - International Marketing & Sales - Marketing and Sales Analysis - Strategic Planning - Financial Planning, Analysis & Reporting - Budget Development & Management - Project Management - System Design/Management/Operation - Merger & Acquisition - Product Localization - Joint Venture Management - Leading independent IB in worldwide, annual amount of transactions in range EUR 2-4m. - worldwide in terms of deal volume and amount in mid-market segment (US$ 5 to 500), ahead of all major global IBs, Big4s, etc. Annual deal volume at US$ 15-20m. - Sell-out of a Korean Resort i. Instrument: Asset Sales ii. Transaction: more than USD$ 800 million - Engaging of Korean Property Development Business i. Instrument: Project Financing ii.Transaction: more than USD$ 100 billion - Development of Substitution Fuel Business i. Instrument: Fund raising, construction and distribution ii. Transaction: more than USD$ 10 million per a plant (more than 5 points) - Fund Raising for Korean BIO company i. Instrument: equity ii.Transaction: more than USD$ 2~30 million etc. - Build up the financial platform for EURASIA with global PE funds